1-4 of 4
Vishwanath Sathyanarayanan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of PD-L1 Expression with Clinico-Pathological Factors and Treatment Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) from a Tertiary Care Cancer Center in Southern India

Free
Pradnya Modak, Swarna Shivakumar, Sabhari Priya, Muthulingesh Kumar, Varsha Bhandarkar, Jahnavi Peddireddy, Kalyani Premchandra, Narendhar Gokulanathan, Arya S. Nath, Neha Surendra Gawarle, Govindarajan Mallarajapatna, Anoop Nagraj P, Channappa Nagraj Patil, Neema Bhat, Poonam Maurya, Vishwanath Sathyanarayanan
Journal: Blood
Blood (2024) 144 (Supplement 1): 6477.
https://doi.org/10.1182/blood-2024-210800
Published: 2024
Journal Articles

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

Free
Kristin A. Simar, RN, ANP-BC, Vishwanath Sathyanarayanan, MD, Amir K Issa, MD, Mohamed Amin Ahmed, MD, Mansoor Noorani, Michelle A Fanale, MD, Yasuhiro Oki, MD, F.B. Hagemeister, MD, Sattva S. Neelapu, MD, Loretta Nastoupil, MD, Nathan Fowler, MD, Francesco Turturro, MD, Richard Eric Davis, MD, Maria Alma Rodriguez, MD, Michael Wang, MD, Lei Feng, MS, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Chelsea C Pinnix, MD PhD, Luis E. Fayad, MD, Jason R. Westin, MD
Journal: Blood
Blood (2016) 128 (22): 4208.
https://doi.org/10.1182/blood.V128.22.4208.4208
Published: 2016
Journal Articles

Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I Results

Free
Jason R. Westin, MD, Vishwanath Sathyanarayanan, MD, Luis E. Fayad, MD, Loretta J. Nastoupil, MD, Francesco Turturro, MD, Fredrick B. Hagemeister, MD, Kristin A. Simar, RN, ANP-BC, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Hubert H Chuang, MD PhD, Fazal Kamil, Lei Feng, MS, Eric Richard Davis, MD, Sattva S. Neelapu, MD, Yasuhiro Oki, MD
Journal: Blood
Blood (2016) 128 (22): 5395.
https://doi.org/10.1182/blood.V128.22.5395.5395
Published: 2016
Journal Articles

High Risk Diffuse Large B Cell Lymphoma: A Comparison of Aggressive Subtypes Treated with Dose Adjusted Chemotherapy-the University of Texas MD Anderson Experience

Free
Vishwanath Sathyanarayanan, MD, Yasuhiro Oki, MD, Amir K Issa, MD, Mohamed Amin Ahmed, MD, Mansoor Noorani, Michelle A Fanale, MD, Fredrick B. Hagemeister, MD, Sattva S. Neelapu, MD, Loretta J. Nastoupil, MD, Nathan Fowler, MD, Francesco Turturro, MD, Eric Richard Davis, MD, Alma Rodriguez, MD, Michael Wang, MD, Lei Feng, MS, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Chelsea C Pinnix, MD PhD, Luis E. Fayad, MD, Jason R. Westin, MD
Journal: Blood
Blood (2016) 128 (22): 106.
https://doi.org/10.1182/blood.V128.22.106.106
Published: 2016